BRAINAURORA-B (06681.HK): DELIGHT Study Shows Brain-Heart Mechanism
NewTimeSpace News: On 19 November 2026, Brain Aurora Medical Technology Limited (stock code: 6681) announced on a voluntary basis that the DELIGHT study, jointly conducted by the group with teams from Beijing Anzhen Hospital and Shanghai Ruijin Hospital, was formally published in eClinicalMedicine, a Lancet sister journal, on 18 November 2026.
The study is a multicentre, double-blind, randomised controlled trial (NCT05704270) carried out across 11 hospitals in China, enrolling 217 patients with hypertension and mild cognitive impairment. Participants were randomly assigned in a 1:1 ratio, with the intervention group receiving 12 weeks of multi-domain adaptive computerised cognitive training and the positive control group receiving training targeting only perception and attention. Both groups used the group's brain function information management platform software system.
The study found that patients receiving multi-domain training not only improved cognitively but also showed significantly better cardiovascular indicators, including lower diastolic blood pressure, steadier heart rate and a marked reduction in the rate-pressure product. Using 7T magnetic resonance imaging, the study revealed a potential mechanism through which cognitive digital therapeutics act via the brain-heart axis. At the 24-week follow-up, the reduction in diastolic blood pressure remained significantly greater than in the control group.
The company said specific data and analysis are subject to the formal paper, and the results do not constitute a connected transaction or a notifiable transaction under the Listing Rules.
- BRAINAURORA-B (06681.HK): Brain Health Contest Holds First Test Round
- Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Soars 52.30% to Lead as Semiconductors and Spatial Intelligence Strengthen - 20261028
- BRAINAURORA-B (06681.HK): Depression Cognitive Assessment Software Wins Class II Device Registration
- Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Leads with 27.13% Gain on Medical Technology as Semiconductors and Medical Devices Both Stay Active - 20261027
- Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Leads with 27.15% Gain on Medical Technology Strength as Robotics Supply Chain Stays Hot - 20261022